Industry

DUBLIN–(BUSINESS WIRE)–The “Hospital Acquired Infection Control Market Research Report by Type (Consumables, Disinfectants, and Disinfectors), Pathogen Type, Indication, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Hospital Acquired Infection Control Market size was … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Oncology Based In-Vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global oncology based in-vivo CRO market reached a value of US$ 1.05 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 1.69 Billion … [Read more…]

ALAMEDA, Calif.–(BUSINESS WIRE)–#CRISPR–Scribe Therapeutics Inc., a molecular engineering company creating the most advanced technologies for CRISPR-based genetic medicine, today announced its participation in the virtual Biopharma Private Company Connect event hosted by SVB Securities on July 20-21, 2022. Company executives, including CEO and co-founder Benjamin Oakes, PhD, and Chief Financial Officer David Parrot, will hold … [Read more…]

Following Agreement With Alladapt Immunotherapeutics, Inc. LAVAL, Quebec–(BUSINESS WIRE)–#Alladapt—Altasciences’ formulation, manufacturing, and analytical services facilities in Philadelphia, PA, are undergoing further expansion. Altasciences—an integrated CRO/CDMO offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies—is building client‑dedicated facilities for Alladapt Immunotherapeutics, Inc. (“Alladapt”), a private, clinical-stage biopharmaceutical company developing prescription … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Wheelchairs Market, by Product Type and Electronic Wheelchair, by Weight, by Modality, by End-user, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. Wheelchairs are primarily designed for disabled individuals for the ease of indoor and outdoor locomotion purposes. Various types of … [Read more…]

Eligible members will pay $0 out of pocket for preferred short and long-acting insulins and emergency use drugs that are critical in acute, life-saving circumstances Action is part of ongoing UnitedHealth Group efforts to improve access and make prescription drugs more affordable for people MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare will eliminate out-of-pocket costs in standard fully insured … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “U.S. Digital Therapeutics Market – Industry Outlook and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. Digital therapeutics plays a significant role in the treatment and disease management of various chronic and mental health conditions. It presents potential solutions for chronic disease management, ranging from congestive heart failure, type 2 diabetes, Alzheimer’s … [Read more…]

A leader in the North American business services industry was recently added to one of the premier tradable global sustainability index funds CINCINNATI–(BUSINESS WIRE)–$CTAS–Cintas Corporation (Nasdaq: CTAS) has been included on the FTSE4Good Index. Created by the global index and data provider FTSE Russell, the FTSE4Good Index Series is designed to measure the performance of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Pharmacovigilance World 2022” conference has been added to ResearchAndMarkets.com’s offering. With the augmented incidence of diseases, and the non-medical use of prescription drugs, the incidence of drug abuse has increased enormously in recent years, which is apparent with the excess documentation of adversities and drug toxicities. In this context, drug safety and pharmacovigilance … [Read more…]

Reflects continued progress in the business combination process; transaction is expected to be completed during the second half of 2022 SAN DIEGO & NORCROSS, Ga.–(BUSINESS WIRE)–Viveon Health Acquisition Corp. (NYSE: VHAQ) (“Viveon Health” or “VHAQ”), a special purpose acquisition company, and Suneva Medical, Inc. (“Suneva” or the “Company”), an innovative medical technology company using regenerative … [Read more…]